Home > Healthcare & Medical Devices > Lung Cancer Market > Table of Contents
Report Content
Chapter 1 Methodology
1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates & working
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Secondary
1.6.1.1 Paid sources
1.6.1.2 Public sources
1.6.2 Primary
Chapter 2 Executive Summary
2.1 Lung cancer industry 360° synopsis, 2018-2032
2.1.1 Business trends
2.1.2 Diagnostics & therapy trends
2.1.3 Indication trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Lung Cancer Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Rising prevalence of lung cancer globally
3.3.1.2 Several initiatives undertaken by public & private organizations to spread disease awareness
3.3.1.3 Technology advancements
3.3.1.4 Rising demand for minimally invasive procedures
3.3.2 Industry pitfalls & challenges
3.3.2.1 Dearth of well-skilled and trained oncologists and radiologists
3.3.2.2 Risk of complications after biopsy
3.3.2.3 High capital investment coupled with high costs associated with cancer treatment
3.4 Growth potential analysis
3.4.1 By diagnostics & therapy
3.4.2 By indication
3.4.3 By end-use
3.5 COVID-19 impact analysis
3.6 Future market trends
3.7 Technology landscape
3.8 Lung cancer epidemiology
3.9 Regulatory landscape
3.9.1 U.S.
3.9.2 Europe
3.10 Reimbursement scenario
3.11 Porter’s analysis
3.12 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Strategic dashboard
Chapter 5 Lung Cancer Market, By Diagnostics & Therapy
5.1 Key diagnostics & therapy trends
5.2 Diagnostics
5.2.1 Market size, by region, 2018 – 2032 (USD Million)
5.2.2 Bronchoscopy
5.2.2.1 Market size, by region, 2018 – 2032 (USD Million)
5.2.3 TTNA
5.2.3.1 Market size, by region, 2018 – 2032 (USD Million)
5.2.4 Imaging
5.2.4.1 Market size, by region, 2018 – 2032 (USD Million)
5.2.5 Tumor Biomarker Test
5.2.5.1 Market size, by region, 2018 – 2032 (USD Million)
5.2.6 In Situ Hybridization
5.2.6.1 Market size, by region, 2018 – 2032 (USD Million)
5.2.7 Others
5.2.7.1 Market size, by region, 2018 – 2032 (USD Million)
5.3 Therapy
5.3.1 Market size, by region, 2018 – 2032 (USD Million)
5.3.2 Non-invasive
5.3.2.1 Market size, by region, 2018 – 2032 (USD Million)
5.3.2.2 Immunotherapy
5.3.2.2.1 Market size, by region, 2018 – 2032 (USD Million)
5.3.2.3 Targeted therapy
5.3.2.3.1 Market size, by region, 2018 – 2032 (USD Million)
5.3.2.4 Others
5.3.2.4.1 Market size, by region, 2018 – 2032 (USD Million)
5.3.3 Minimally invasive
5.3.3.1 Market size, by region, 2018 – 2032 (USD Million)
5.3.3.2 Radiofrequency ablation
5.3.3.2.1 Market size, by region, 2018 – 2032 (USD Million)
5.3.3.3 Microwave ablation
5.3.3.3.1 Market size, by region, 2018 – 2032 (USD Million)
5.3.3.4 Thermal/cryoablation
5.3.3.4.1 Market size, by region, 2018 – 2032 (USD Million)
5.3.3.5 Others
5.3.3.5.1 Market size, by region, 2018 – 2032 (USD Million)
Chapter 6 Lung Cancer Market, By Indication
6.1 Key indication trend
6.2 Non-small cell lung cancer
6.2.1 Market size, by region, 2018 – 2032 (USD Million)
6.3 Small cell lung cancer
6.3.1 Market size, by region, 2018 – 2032 (USD Million)
Chapter 7 Lung Cancer Market, By End-use
7.1 Key end-use trend
7.2 Hospitals
7.2.1 Market size, by region, 2018 – 2032 (USD Million)
7.3 Diagnostic laboratories
7.3.1 Market size, by region, 2018 – 2032 (USD Million)
7.4 Diagnostic imaging centers
7.4.1 Market size, by region, 2018 – 2032 (USD Million)
7.5 Academia
7.5.1 Market size, by region, 2018 – 2032 (USD Million)
7.6 Specialty clinics
7.6.1 Market size, by region, 2018 – 2032 (USD Million)
7.7 Others
7.7.1 Market size, by region, 2018 – 2032 (USD Million)
Chapter 8 Lung Cancer Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 Market size, by country, 2018 – 2032 (USD Million)
8.2.2 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.2.2.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.2.2.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.2.2.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.2.2.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.2.3 Market size, by indication, 2018 – 2032 (USD Million)
8.2.4 Market size, by end-use, 2018 – 2032 (USD Million)
8.2.5 U.S.
8.2.5.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.2.5.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.2.5.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.2.5.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.2.5.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.2.5.2 Market size, by indication, 2018 – 2032 (USD Million)
8.2.5.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.2.6 Canada
8.2.6.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.2.6.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.2.6.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.2.6.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.2.6.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.2.6.2 Market size, by indication, 2018 – 2032 (USD Million)
8.2.6.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.3 Europe
8.3.1 Market size, by country, 2018 – 2032 (USD Million)
8.3.2 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.3.2.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.3.2.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.3.2.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.3.2.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.3.3 Market size, by indication, 2018 – 2032 (USD Million)
8.3.4 Market size, by end-use, 2018 – 2032 (USD Million)
8.3.5 Germany
8.3.5.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.3.5.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.3.5.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.3.5.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.3.5.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.3.5.2 Market size, by indication, 2018 – 2032 (USD Million)
8.3.5.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.3.6 UK
8.3.6.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.3.6.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.3.6.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.3.6.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.3.6.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.3.6.2 Market size, by indication, 2018 – 2032 (USD Million)
8.3.6.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.3.7 France
8.3.7.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.3.7.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.3.7.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.3.7.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.3.7.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.3.7.2 Market size, by indication, 2018 – 2032 (USD Million)
8.3.7.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.3.8 Italy
8.3.8.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.3.8.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.3.8.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.3.8.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.3.8.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.3.8.2 Market size, by indication, 2018 – 2032 (USD Million)
8.3.8.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.3.9 Spain
8.3.9.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.3.9.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.3.9.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.3.9.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.3.9.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.3.9.2 Market size, by indication, 2018 – 2032 (USD Million)
8.3.9.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.4 Asia Pacific
8.4.1 Market size, by country, 2018 – 2032 (USD Million)
8.4.2 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.4.2.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.4.2.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.4.2.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.4.2.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.4.3 Market size, by indication, 2018 – 2032 (USD Million)
8.4.4 Market size, by end-use, 2018 – 2032 (USD Million)
8.4.5 China
8.4.5.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.4.5.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.4.5.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.4.5.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.4.5.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.4.5.2 Market size, by indication, 2018 – 2032 (USD Million)
8.4.5.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.4.6 Japan
8.4.6.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.4.6.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.4.6.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.4.6.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.4.6.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.4.6.2 Market size, by indication, 2018 – 2032 (USD Million)
8.4.6.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.4.7 India
8.4.7.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.4.7.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.4.7.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.4.7.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.4.7.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.4.7.2 Market size, by indication, 2018 – 2032 (USD Million)
8.4.7.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.4.8 Australia
8.4.8.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.4.8.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.4.8.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.4.8.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.4.8.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.4.8.2 Market size, by indication, 2018 – 2032 (USD Million)
8.4.8.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.5 Latin America
8.5.1 Market size, by country, 2018 – 2032 (USD Million)
8.5.2 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.5.2.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.5.2.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.5.2.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.5.2.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.5.3 Market size, by indication, 2018 – 2032 (USD Million)
8.5.4 Market size, by end-use, 2018 – 2032 (USD Million)
8.5.5 Brazil
8.5.5.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.5.5.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.5.5.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.5.5.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.5.5.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.5.5.2 Market size, by indication, 2018 – 2032 (USD Million)
8.5.5.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.5.6 Mexico
8.5.6.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.5.6.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.5.6.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.5.6.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.5.6.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.5.6.2 Market size, by indication, 2018 – 2032 (USD Million)
8.5.6.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.5.7 Argentina
8.5.7.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.5.7.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.5.7.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.5.7.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.5.7.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.5.7.2 Market size, by indication, 2018 – 2032 (USD Million)
8.5.7.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.6 MEA
8.6.1 Market size, by country, 2018 – 2032 (USD Million)
8.6.2 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.6.2.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.6.2.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.6.2.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.6.2.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.6.3 Market size, by indication, 2018 – 2032 (USD Million)
8.6.4 Market size, by end-use, 2018 – 2032 (USD Million)
8.6.5 South Africa
8.6.5.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.6.5.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.6.5.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.6.5.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.6.5.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.6.5.2 Market size, by indication, 2018 – 2032 (USD Million)
8.6.5.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.6.6 Saudi Arabia
8.6.6.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.6.6.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.6.6.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.6.6.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.6.6.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.6.6.2 Market size, by indication, 2018 – 2032 (USD Million)
8.6.6.3 Market size, by end-use, 2018 – 2032 (USD Million)
8.6.7 UAE
8.6.7.1 Market size, by diagnostics & therapy, 2018 – 2032 (USD Million)
8.6.7.1.1 Market size, by diagnostics, 2018 - 2032 (USD Million)
8.6.7.1.2 Market size, by therapy, 2018 - 2032 (USD Million)
8.6.7.1.2.1 Market size, by non-invasive, 2018 - 2032 (USD Million)
8.6.7.1.2.2 Market size, by minimally invasive, 2018 - 2032 (USD Million)
8.6.7.2 Market size, by indication, 2018 – 2032 (USD Million)
8.6.7.3 Market size, by end-use, 2018 – 2032 (USD Million)
Chapter 9 Company Profiles
9.1 F. Hoffmann-La Roche
9.1.1 Business overview
9.1.2 Financial data
9.1.3 Service landscape
9.1.4 SWOT analysis
9.2 AstraZeneca
9.2.1 Business overview
9.2.2 Financial data
9.2.3 Service landscape
9.2.4 SWOT analysis
9.3 Sanofi
9.3.1 Business overview
9.3.2 Financial data
9.3.3 Service landscape
9.3.4 SWOT analysis
9.4 Pfizer, Inc.
9.4.1 Business overview
9.4.2 Financial data
9.4.3 Service landscape
9.4.4 SWOT analysis
9.5 Bristol-Myers Squibb Company
9.5.1 Business overview
9.5.2 Financial data
9.5.3 Service landscape
9.5.4 SWOT analysis
9.6 Sysmex Corporation
9.6.1 Business overview
9.6.2 Financial data
9.6.3 Service landscape
9.6.4 SWOT analysis
9.7 Thermo Fischer Scientific
9.7.1 Business overview
9.7.2 Financial data
9.7.3 Service landscape
9.7.4 SWOT analysis
9.8 Qiagen
9.8.1 Business overview
9.8.2 Financial data
9.8.3 Service landscape
9.8.4 SWOT analysis
9.9 Janssen Pharmaceuticals
9.9.1 Business overview
9.9.2 Financial data
9.9.3 Service landscape
9.9.4 SWOT analysis
9.10 Quest Diagnostics
9.10.1 Business overview
9.10.2 Financial data
9.10.3 Service landscape
9.10.4 SWOT analysis
9.11 Takeda Pharmaceutical Company
9.11.1 Business overview
9.11.2 Financial data
9.11.3 Service landscape
9.11.4 SWOT analysis
9.12 Novartis AG.
9.12.1 Business overview
9.12.2 Financial data
9.12.3 Service landscape
9.12.4 SWOT analysis
9.13 Eli Lilly & Company (Lilly)
9.13.1 Business overview
9.13.2 Financial data
9.13.3 Service landscape
9.13.4 SWOT analysis
9.14 Merck & Co. Inc.
9.14.1 Business overview
9.14.2 Financial data
9.14.3 Service landscape
9.14.4 SWOT analysis
Data Tables
TABLE 1. Global lung cancer market, 2018 - 2022 (USD Million)
TABLE 2. Global lung cancer market, 2023 - 2032 (USD Million)
TABLE 3. Global lung cancer market, by diagnostics & therapy, 2018 - 2022 (USD Million)
TABLE 4. Global lung cancer market, by diagnostics & therapy, 2023 - 2032 (USD Million)
TABLE 5. Global lung cancer market, by indication, 2018 - 2022 (USD Million)
TABLE 6. Global lung cancer market, by indication, 2023 - 2032 (USD Million)
TABLE 7. Global lung cancer market, by end-use, 2018 - 2022 (USD Million)
TABLE 8. Global lung cancer market, by end-use, 2023 - 2032 (USD Million)
TABLE 9. Global lung cancer market, by region, 2018 - 2022 (USD Million)
TABLE 10. Global lung cancer market, by region, 2023 - 2032 (USD Million)
TABLE 11. Industry impact forces
TABLE 12. Diagnostics market, by region, 2018 - 2022, (USD Million)
TABLE 13. Diagnostics market, by region, 2023 - 2032, (USD Million)
TABLE 14. Bronchoscopy market, by region, 2018 - 2022, (USD Million)
TABLE 15. Bronchoscopy market, by region, 2023-2032, (USD Million)
TABLE 16. Transthoracic needle aspiration market, by region, 2018 - 2022, (USD Million)
TABLE 17. Transthoracic needle aspiration market, by region, 2023-2032, (USD Million)
TABLE 18. Imaging market, by region, 2018 - 2022, (USD Million)
TABLE 19. Imaging market, by region, 2023-2032, (USD Million)
TABLE 20. Tumor biomarker test market, by region, 2018 - 2022, (USD Million)
TABLE 21. Tumor biomarker test market, by region, 2023-2032, (USD Million)
TABLE 22. In situ hybridization market, by region, 2018 - 2022, (USD Million)
TABLE 23. In situ hybridization market, by region, 2023-2032, (USD Million)
TABLE 24. Others market, by region, 2018 - 2022, (USD Million)
TABLE 25. Others market, by region, 2023-2032, (USD Million)
TABLE 26. Therapy market, by region, 2018 - 2022, (USD Million)
TABLE 27. Therapy market, by region, 2023-2032, (USD Million)
TABLE 28. Non-invasive market, by region, 2018 - 2022, (USD Million)
TABLE 29. Non-invasive market, by region, 2023-2032, (USD Million)
TABLE 30. Immunotherapy market, by region, 2018 - 2022, (USD Million)
TABLE 31. Immunotherapy market, by region, 2023-2032, (USD Million)
TABLE 32. Targeted therapy market, by region, 2018 - 2022, (USD Million)
TABLE 33. Targeted therapy market, by region, 2023-2032, (USD Million)
TABLE 34. Others market, by region, 2018 - 2022, (USD Million)
TABLE 35. Others market, by region, 2023-2032, (USD Million)
TABLE 36. Minimally invasive market, by region, 2018 - 2022, (USD Million)
TABLE 37. Minimally invasive market, by region, 2023-2032, (USD Million)
TABLE 38. Radiofrequency ablation market, by region, 2018 - 2022, (USD Million)
TABLE 39. Radiofrequency ablation market, by region, 2023-2032, (USD Million)
TABLE 40. Microwave ablation market, by region, 2018 - 2022, (USD Million)
TABLE 41. Microwave ablation market, by region, 2023-2032, (USD Million)
TABLE 42. Thermal/Cryoablation market, by region, 2018 - 2022, (USD Million)
TABLE 43. Thermal/Cryoablation market, by region, 2023-2032, (USD Million)
TABLE 44. Others market, by region, 2018 - 2022, (USD Million)
TABLE 45. Others market, by region, 2023-2032, (USD Million)
TABLE 46. NSCLC market, by region, 2018 - 2022, (USD Million)
TABLE 47. NSCLC market, by region, 2023-2032, (USD Million)
TABLE 48. SCLC market, by region, 2018 - 2022, (USD Million)
TABLE 49. SCLC market, by region, 2023-2032, (USD Million)
TABLE 50. Hospitals market, by region, 2018 - 2022, (USD Million)
TABLE 51. Hospitals market, by region, 2023-2032, (USD Million)
TABLE 52. Diagnostic laboratories market, by region, 2018 - 2022, (USD Million)
TABLE 53. Diagnostic laboratories market, by region, 2023-2032, (USD Million)
TABLE 54. Diagnostic imaging centers market, by region, 2018 - 2022, (USD Million)
TABLE 55. Diagnostic imaging centers market, by region, 2023-2032, (USD Million)
TABLE 56. Academia market, by region, 2018 - 2022, (USD Million)
TABLE 57. Academia market, by region, 2023-2032, (USD Million)
TABLE 58. Specialty clinics market, by region, 2018 - 2022, (USD Million)
TABLE 59. Specialty clinics market, by region, 2023-2032, (USD Million)
TABLE 60. Others market, by region, 2018 - 2022, (USD Million)
TABLE 61. Others market, by region, 2023-2032, (USD Million)
TABLE 62. North America lung cancer market, by country, 2018-2022, (USD Million)
TABLE 63. North America lung cancer market, by country, 2023-2032, (USD Million)
TABLE 64. North America lung cancer market, by diagnostics & therapy, 2018-2022, (USD Million)
TABLE 65. North America lung cancer market, by diagnostics & therapy, 2023-2032, (USD Million)
TABLE 66. North America lung cancer market, by diagnostics, 2018-2022, (USD Million)
TABLE 67. North America lung cancer market, by diagnostics, 2023-2032, (USD Million)
TABLE 68. North America lung cancer market, by therapy, 2018-2022, (USD Million)
TABLE 69. North America lung cancer market, by therapy, 2023-2032, (USD Million)
TABLE 70. North America lung cancer market, by non-invasive, 2018-2022, (USD Million)
TABLE 71. North America lung cancer market, by non-invasive, 2023-2032, (USD Million)
TABLE 72. North America lung cancer market, by minimally invasive, 2018-2022, (USD Million)
TABLE 73. North America lung cancer market, by minimally invasive, 2023-2032, (USD Million)
TABLE 74. North America lung cancer market, by indication, 2018-2022, (USD Million)
TABLE 75. North America lung cancer market, by indication, 2023-2032, (USD Million)
TABLE 76. North America lung cancer market, by end-use, 2018-2022, (USD Million)
TABLE 77. North America lung cancer market, by end-use, 2023-2032, (USD Million)
TABLE 78. U.S. lung cancer market, by diagnostics & therapy, 2018-2022, (USD Million)
TABLE 79. U.S. lung cancer market, by diagnostics & therapy, 2023-2032, (USD Million)
TABLE 80. U.S. lung cancer market, by diagnostics, 2018-2022, (USD Million)
TABLE 81. U.S. lung cancer market, by diagnostics, 2023-2032, (USD Million)
TABLE 82. U.S. lung cancer market, by therapy, 2018-2022, (USD Million)
TABLE 83. U.S. lung cancer market, by therapy, 2023-2032, (USD Million)
TABLE 84. U.S. lung cancer market, by non-invasive, 2018-2022, (USD Million)
TABLE 85. U.S. lung cancer market, by non-invasive, 2023-2032, (USD Million)
TABLE 86. U.S. lung cancer market, by minimally invasive, 2018-2022, (USD Million)
TABLE 87. U.S. lung cancer market, by minimally invasive, 2023-2032, (USD Million)
TABLE 88. U.S. lung cancer market, by indication, 2018-2022, (USD Million)
TABLE 89. U.S. lung cancer market, by indication, 2023-2032, (USD Million)
TABLE 90. U.S. lung cancer market, by end-use, 2018-2022, (USD Million)
TABLE 91. U.S. lung cancer market, by end-use, 2023-2032, (USD Million)
TABLE 92. Canada lung cancer market, by diagnostics & therapy, 2018-2022, (USD Million)
TABLE 93. Canada lung cancer market, by diagnostics & therapy, 2023-2032, (USD Million)
TABLE 94. Canada lung cancer market, by diagnostics, 2018-2022, (USD Million)
TABLE 95. Canada lung cancer market, by diagnostics, 2023-2032, (USD Million)
TABLE 96. Canada lung cancer market, by therapy, 2018-2022, (USD Million)
TABLE 97. Canada lung cancer market, by therapy, 2023-2032, (USD Million)
TABLE 98. Canada lung cancer market, by non-invasive, 2018-2022, (USD Million)
TABLE 99. Canada lung cancer market, by non-invasive, 2023-2032, (USD Million)
TABLE 100. Canada lung cancer market, by minimally invasive, 2018-2022, (USD Million)
TABLE 101. Canada lung cancer market, by minimally invasive, 2023-2032, (USD Million)
TABLE 102. Canada lung cancer market, by indication, 2018-2022, (USD Million)
TABLE 103. Canada lung cancer market, by indication, 2023-2032, (USD Million)
TABLE 104. Canada lung cancer market, by end-use, 2018-2022, (USD Million)
TABLE 105. Canada lung cancer market, by end-use, 2023-2032, (USD Million)
TABLE 106. Europe lung cancer market, by country, 2018-2022, (USD Million)
TABLE 107. Europe lung cancer market, by country, 2023-2032, (USD Million)
TABLE 108. Europe lung cancer market, by diagnostics & therapy, 2018-2022, (USD Million)
TABLE 109. Europe lung cancer market, by diagnostics & therapy, 2023-2032, (USD Million)
TABLE 110. Europe lung cancer market, by diagnostics, 2018-2022, (USD Million)
TABLE 111. Europe lung cancer market, by diagnostics, 2023-2032, (USD Million)
TABLE 112. Europe lung cancer market, by therapy, 2018-2022, (USD Million)
TABLE 113. North America lung cancer market, by therapy, 2023-2032, (USD Million)
TABLE 114. Europe lung cancer market, by non-invasive, 2018-2022, (USD Million)
TABLE 115. Europe lung cancer market, by non-invasive, 2023-2032, (USD Million)
TABLE 116. Europe lung cancer market, by minimally invasive, 2018-2022, (USD Million)
TABLE 117. Europe lung cancer market, by minimally invasive, 2023-2032, (USD Million)
TABLE 118. Europe lung cancer market, by indication, 2018-2022, (USD Million)
TABLE 119. Europe lung cancer market, by indication, 2023-2032, (USD Million)
TABLE 120. Europe lung cancer market, by end-use, 2018-2022, (USD Million)
TABLE 121. Europe lung cancer market, by end-use, 2023-2032, (USD Million)
TABLE 122. Germany lung cancer market, by diagnostics & therapy, 2018-2022, (USD Million)
TABLE 123. Germany lung cancer market, by diagnostics & therapy, 2023-2032, (USD Million)
TABLE 124. Germany lung cancer market, by diagnostics, 2018-2022, (USD Million)
TABLE 125. Germany lung cancer market, by diagnostics, 2023-2032, (USD Million)
TABLE 126. Germany lung cancer market, by therapy, 2018-2022, (USD Million)
TABLE 127. Germany lung cancer market, by therapy, 2023-2032, (USD Million)
TABLE 128. Germany lung cancer market, by non-invasive, 2018-2022, (USD Million)
TABLE 129. Germany lung cancer market, by non-invasive, 2023-2032, (USD Million)
TABLE 130. Germany lung cancer market, by minimally invasive, 2018-2022, (USD Million)
TABLE 131. Germany lung cancer market, by minimally invasive, 2023-2032, (USD Million)
TABLE 132. Germany lung cancer market, by indication, 2018-2022, (USD Million)
TABLE 133. Germany lung cancer market, by indication, 2023-2032, (USD Million)
TABLE 134. Germany lung cancer market, by end-use, 2018-2022, (USD Million)
TABLE 135. Germany lung cancer market, by end-use, 2023-2032, (USD Million)
TABLE 136. UK lung cancer market, by diagnostics & therapy, 2018-2022, (USD Million)
TABLE 137. UK lung cancer market, by diagnostics & therapy, 2023-2032, (USD Million)
TABLE 138. UK lung cancer market, by diagnostics, 2018-2022, (USD Million)
TABLE 139. UK lung cancer market, by diagnostics, 2023-2032, (USD Million)
TABLE 140. UK lung cancer market, by therapy, 2018-2022, (USD Million)
TABLE 141. UK lung cancer market, by therapy, 2023-2032, (USD Million)
TABLE 142. UK lung cancer market, by non-invasive, 2018-2022, (USD Million)
TABLE 143. UK lung cancer market, by non-invasive, 2023-2032, (USD Million)
TABLE 144. UK lung cancer market, by minimally invasive, 2018-2022, (USD Million)
TABLE 145. UK lung cancer market, by minimally invasive, 2023-2032, (USD Million)
TABLE 146. UK lung cancer market, by indication, 2018-2022, (USD Million)
TABLE 147. UK lung cancer market, by indication, 2023-2032, (USD Million)
TABLE 148. UK lung cancer market, by end-use, 2018-2022, (USD Million)
TABLE 149. UK lung cancer market, by end-use, 2023-2032, (USD Million)
TABLE 150. France lung cancer market, by diagnostics & therapy, 2018-2022, (USD Million)
TABLE 151. France lung cancer market, by diagnostics & therapy, 2023-2032, (USD Million)
TABLE 152. France lung cancer market, by diagnostics, 2018-2022, (USD Million)
TABLE 153. France lung cancer market, by diagnostics, 2023-2032, (USD Million)
TABLE 154. France lung cancer market, by therapy, 2018-2022, (USD Million)
TABLE 155. France lung cancer market, by therapy, 2023-2032, (USD Million)
TABLE 156. France lung cancer market, by non-invasive, 2018-2022, (USD Million)
TABLE 157. France lung cancer market, by non-invasive, 2023-2032, (USD Million)
TABLE 158. France lung cancer market, by minimally invasive, 2018-2022, (USD Million)
TABLE 159. France lung cancer market, by minimally invasive, 2023-2032, (USD Million)
TABLE 160. France lung cancer market, by indication, 2018-2022, (USD Million)
TABLE 161. France lung cancer market, by indication, 2023-2032, (USD Million)
TABLE 162. France lung cancer market, by end-use, 2018-2022, (USD Million)
TABLE 163. France lung cancer market, by end-use, 2023-2032, (USD Million)
TABLE 164. Spain lung cancer market, by diagnostics & therapy, 2018-2022, (USD Million)
TABLE 165. Spain lung cancer market, by diagnostics & therapy, 2023-2032, (USD Million)
TABLE 166. Spain lung cancer market, by diagnostics, 2018-2022, (USD Million)
TABLE 167. Spain lung cancer market, by diagnostics, 2023-2032, (USD Million)
TABLE 168. Spain lung cancer market, by therapy, 2018-2022, (USD Million)
TABLE 169. Spain lung cancer market, by therapy, 2023-2032, (USD Million)
TABLE 170. Spain lung cancer market, by non-invasive, 2018-2022, (USD Million)
TABLE 171. Spain lung cancer market, by non-invasive, 2023-2032, (USD Million)
TABLE 172. Spain lung cancer market, by minimally invasive, 2018-2022, (USD Million)
TABLE 173. Spain lung cancer market, by minimally invasive, 2023-2032, (USD Million)
TABLE 174. Spain lung cancer market, by indication, 2018-2022, (USD Million)
TABLE 175. Spain lung cancer market, by indication, 2023-2032, (USD Million)
TABLE 176. Spain lung cancer market, by end-use, 2018-2022, (USD Million)
TABLE 177. Spain lung cancer market, by end-use, 2023-2032, (USD Million)
TABLE 178. Italy lung cancer market, by diagnostics & therapy, 2018-2022, (USD Million)
TABLE 179. Italy lung cancer market, by diagnostics & therapy, 2023-2032, (USD Million)
TABLE 180. Italy lung cancer market, by diagnostics, 2018-2022, (USD Million)
TABLE 181. Italy lung cancer market, by diagnostics, 2023-2032, (USD Million)
TABLE 182. Italy lung cancer market, by therapy, 2018-2022, (USD Million)
TABLE 183. Italy lung cancer market, by therapy, 2023-2032, (USD Million)
TABLE 184. Italy lung cancer market, by non-invasive, 2018-2022, (USD Million)
TABLE 185. Italy lung cancer market, by non-invasive, 2023-2032, (USD Million)
TABLE 186. Italy lung cancer market, by minimally invasive, 2018-2022, (USD Million)
TABLE 187. Italy lung cancer market, by minimally invasive, 2023-2032, (USD Million)
TABLE 188. Italy lung cancer market, by indication, 2018-2022, (USD Million)
TABLE 189. Italy lung cancer market, by indication, 2023-2032, (USD Million)
TABLE 190. Italy lung cancer market, by end-use, 2018-2022, (USD Million)
TABLE 191. Italy lung cancer market, by end-use, 2023-2032, (USD Million)
TABLE 192. Asia Pacific lung cancer market, by country, 2018-2022, (USD Million)
TABLE 193. Asia Pacific lung cancer market, by country, 2023-2032, (USD Million)
TABLE 194. Asia Pacific lung cancer market, by diagnostics & therapy, 2018-2022, (USD Million)
TABLE 195. Asia Pacific lung cancer market, by diagnostics & therapy, 2023-2032, (USD Million)
TABLE 196. Asia Pacific lung cancer market, by diagnostics, 2018-2022, (USD Million)
TABLE 197. Asia Pacific lung cancer market, by diagnostics, 2023-2032, (USD Million)
TABLE 198. Asia Pacific lung cancer market, by therapy, 2018-2022, (USD Million)
TABLE 199. Asia Pacific lung cancer market, by therapy, 2023-2032, (USD Million)
TABLE 200. Asia Pacific lung cancer market, by non-invasive, 2018-2022, (USD Million)
TABLE 201. Asia Pacific lung cancer market, by non-invasive, 2023-2032, (USD Million)
TABLE 202. Asia Pacific lung cancer market, by minimally invasive, 2018-2022, (USD Million)
TABLE 203. Asia Pacific lung cancer market, by minimally invasive, 2023-2032, (USD Million)
TABLE 204. Asia Pacific lung cancer market, by indication, 2018-2022, (USD Million)
TABLE 205. Asia Pacific lung cancer market, by indication, 2023-2032, (USD Million)
TABLE 206. Asia Pacific lung cancer market, by end-use, 2018-2022, (USD Million)
TABLE 207. Asia Pacific lung cancer market, by end-use, 2023-2032, (USD Million)
TABLE 208. China lung cancer market, by diagnostics & therapy, 2018-2022, (USD Million)
TABLE 209. China lung cancer market, by diagnostics & therapy, 2023-2032, (USD Million)
TABLE 210. China lung cancer market, by diagnostics, 2018-2022, (USD Million)
TABLE 211. China lung cancer market, by diagnostics, 2023-2032, (USD Million)
TABLE 212. China lung cancer market, by therapy, 2018-2022, (USD Million)
TABLE 213. China lung cancer market, by therapy, 2023-2032, (USD Million)
TABLE 214. China lung cancer market, by non-invasive, 2018-2022, (USD Million)
TABLE 215. China lung cancer market, by non-invasive, 2023-2032, (USD Million)
TABLE 216. China lung cancer market, by minimally invasive, 2018-2022, (USD Million)
TABLE 217. China lung cancer market, by minimally invasive, 2023-2032, (USD Million)
TABLE 218. China lung cancer market, by indication, 2018-2022, (USD Million)
TABLE 219. China lung cancer market, by indication, 2023-2032, (USD Million)
TABLE 220. China lung cancer market, by end-use, 2018-2022, (USD Million)
TABLE 221. China lung cancer market, by end-use, 2023-2032, (USD Million)
TABLE 222. Japan lung cancer market, by diagnostics & therapy, 2018-2022, (USD Million)
TABLE 223. Japan lung cancer market, by diagnostics & therapy, 2023-2032, (USD Million)
TABLE 224. Japan lung cancer market, by diagnostics, 2018-2022, (USD Million)
TABLE 225. Japan lung cancer market, by diagnostics, 2023-2032, (USD Million)
TABLE 226. Japan lung cancer market, by therapy, 2018-2022, (USD Million)
TABLE 227. Japan lung cancer market, by therapy, 2023-2032, (USD Million)
TABLE 228. Japan lung cancer market, by non-invasive, 2018-2022, (USD Million)
TABLE 229. Japan lung cancer market, by non-invasive, 2023-2032, (USD Million)
TABLE 230. Japan lung cancer market, by minimally invasive, 2018-2022, (USD Million)
TABLE 231. Japan lung cancer market, by minimally invasive, 2023-2032, (USD Million)
TABLE 232. Japan lung cancer market, by indication, 2018-2022, (USD Million)
TABLE 233. Japan lung cancer market, by indication, 2023-2032, (USD Million)
TABLE 234. Japan lung cancer market, by end-use, 2018-2022, (USD Million)
TABLE 235. Japan lung cancer market, by end-use, 2023-2032, (USD Million)
TABLE 236. India lung cancer market, by diagnostics & therapy, 2018-2022, (USD Million)
TABLE 237. India lung cancer market, by diagnostics & therapy, 2023-2032, (USD Million)
TABLE 238. India lung cancer market, by diagnostics, 2018-2022, (USD Million)
TABLE 239. India lung cancer market, by diagnostics, 2023-2032, (USD Million)
TABLE 240. India lung cancer market, by therapy, 2018-2022, (USD Million)
TABLE 241. India lung cancer market, by therapy, 2023-2032, (USD Million)
TABLE 242. India lung cancer market, by non-invasive, 2018-2022, (USD Million)
TABLE 243. India lung cancer market, by non-invasive, 2023-2032, (USD Million)
TABLE 244. India lung cancer market, by minimally invasive, 2018-2022, (USD Million)
TABLE 245. India lung cancer market, by minimally invasive, 2023-2032, (USD Million)
TABLE 246. India lung cancer market, by indication, 2018-2022, (USD Million)
TABLE 247. India lung cancer market, by indication, 2023-2032, (USD Million)
TABLE 248. India lung cancer market, by end-use, 2018-2022, (USD Million)
TABLE 249. India lung cancer market, by end-use, 2023-2032, (USD Million)
TABLE 250. Australia lung cancer market, by diagnostics & therapy, 2018-2022, (USD Million)
TABLE 251. Australia lung cancer market, by diagnostics & therapy, 2023-2032, (USD Million)
TABLE 252. Australia lung cancer market, by diagnostics, 2018-2022, (USD Million)
TABLE 253. Australia lung cancer market, by diagnostics, 2023-2032, (USD Million)
TABLE 254. Australia lung cancer market, by therapy, 2018-2022, (USD Million)
TABLE 255. Australia. lung cancer market, by therapy, 2023-2032, (USD Million)
TABLE 256. Australia lung cancer market, by non-invasive, 2018-2022, (USD Million)
TABLE 257. Australia lung cancer market, by non-invasive, 2023-2032, (USD Million)
TABLE 258. Australia lung cancer market, by minimally invasive, 2018-2022, (USD Million)
TABLE 259. Australia lung cancer market, by minimally invasive, 2023-2032, (USD Million)
TABLE 260. Australia lung cancer market, by indication, 2018-2022, (USD Million)
TABLE 261. Australia lung cancer market, by indication, 2023-2032, (USD Million)
TABLE 262. Australia lung cancer market, by end-use, 2018-2022, (USD Million)
TABLE 263. Australia lung cancer market, by end-use, 2023-2032, (USD Million)
TABLE 264. Latin America lung cancer market, by country, 2018-2022, (USD Million)
TABLE 265. Latin America lung cancer market, by country, 2023-2032, (USD Million)
TABLE 266. Latin America lung cancer market, by diagnostics & therapy, 2018-2022, (USD Million)
TABLE 267. Latin America lung cancer market, by diagnostics & therapy, 2023-2032, (USD Million)
TABLE 268. Latin America lung cancer market, by diagnostics, 2018-2022, (USD Million)
TABLE 269. Latin America lung cancer market, by diagnostics, 2023-2032, (USD Million)
TABLE 270. Latin America lung cancer market, by therapy, 2018-2022, (USD Million)
TABLE 271. Latin America lung cancer market, by therapy, 2023-2032, (USD Million)
TABLE 272. Latin America lung cancer market, by non-invasive, 2018-2022, (USD Million)
TABLE 273. Latin America lung cancer market, by non-invasive, 2023-2032, (USD Million)
TABLE 274. Latin America lung cancer market, by minimally invasive, 2018-2022, (USD Million)
TABLE 275. Latin America lung cancer market, by minimally invasive, 2023-2032, (USD Million)
TABLE 276. Latin America lung cancer market, by indication, 2018-2022, (USD Million)
TABLE 277. Latin America lung cancer market, by indication, 2023-2032, (USD Million)
TABLE 278. Latin America lung cancer market, by end-use, 2018-2022, (USD Million)
TABLE 279. Latin America lung cancer market, by end-use, 2023-2032, (USD Million)
TABLE 280. Brazil lung cancer market, by diagnostics & therapy, 2018-2022, (USD Million)
TABLE 281. Brazil lung cancer market, by diagnostics & therapy, 2023-2032, (USD Million)
TABLE 282. Brazil lung cancer market, by diagnostics, 2018-2022, (USD Million)
TABLE 283. Brazil lung cancer market, by diagnostics, 2023-2032, (USD Million)
TABLE 284. Brazil lung cancer market, by therapy, 2018-2022, (USD Million)
TABLE 285. Brazil lung cancer market, by therapy, 2023-2032, (USD Million)
TABLE 286. Brazil lung cancer market, by non-invasive, 2018-2022, (USD Million)
TABLE 287. Brazil lung cancer market, by non-invasive, 2023-2032, (USD Million)
TABLE 288. Brazil lung cancer market, by minimally invasive, 2018-2022, (USD Million)
TABLE 289. Brazil lung cancer market, by minimally invasive, 2023-2032, (USD Million)
TABLE 290. Brazil lung cancer market, by indication, 2018-2022, (USD Million)
TABLE 291. Brazil lung cancer market, by indication, 2023-2032, (USD Million)
TABLE 292. Brazil lung cancer market, by end-use, 2018-2022, (USD Million)
TABLE 293. Brazil lung cancer market, by end-use, 2023-2032, (USD Million)
TABLE 294. Mexico lung cancer market, by diagnostics & therapy, 2018-2022, (USD Million)
TABLE 295. Mexico lung cancer market, by diagnostics & therapy, 2023-2032, (USD Million)
TABLE 296. Mexico lung cancer market, by diagnostics, 2018-2022, (USD Million)
TABLE 297. Mexico lung cancer market, by diagnostics, 2023-2032, (USD Million)
TABLE 298. Mexico lung cancer market, by therapy, 2018-2022, (USD Million)
TABLE 299. Mexico lung cancer market, by therapy, 2023-2032, (USD Million)
TABLE 300. Mexico lung cancer market, by non-invasive, 2018-2022, (USD Million)
TABLE 301. Mexico lung cancer market, by non-invasive, 2023-2032, (USD Million)
TABLE 302. Mexico lung cancer market, by minimally invasive, 2018-2022, (USD Million)
TABLE 303. Mexico lung cancer market, by minimally invasive, 2023-2032, (USD Million)
TABLE 304. Mexico lung cancer market, by indication, 2018-2022, (USD Million)
TABLE 305. Mexico lung cancer market, by indication, 2023-2032, (USD Million)
TABLE 306. Mexico lung cancer market, by end-use, 2018-2022, (USD Million)
TABLE 307. Mexico lung cancer market, by end-use, 2023-2032, (USD Million)
TABLE 308. Argentina lung cancer market, by diagnostics & therapy, 2018-2022, (USD Million)
TABLE 309. Argentina lung cancer market, by diagnostics & therapy, 2023-2032, (USD Million)
TABLE 310. Argentina lung cancer market, by diagnostics, 2018-2022, (USD Million)
TABLE 311. Argentina lung cancer market, by diagnostics, 2023-2032, (USD Million)
TABLE 312. Argentina lung cancer market, by therapy, 2018-2022, (USD Million)
TABLE 313. Argentina lung cancer market, by therapy, 2023-2032, (USD Million)
TABLE 314. Argentina lung cancer market, by non-invasive, 2018-2022, (USD Million)
TABLE 315. Argentina lung cancer market, by non-invasive, 2023-2032, (USD Million)
TABLE 316. Argentina lung cancer market, by minimally invasive, 2018-2022, (USD Million)
TABLE 317. Argentina lung cancer market, by minimally invasive, 2023-2032, (USD Million)
TABLE 318. Argentina lung cancer market, by indication, 2018-2022, (USD Million)
TABLE 319. Argentina lung cancer market, by indication, 2023-2032, (USD Million)
TABLE 320. Argentina lung cancer market, by end-use, 2018-2022, (USD Million)
TABLE 321. Argentina lung cancer market, by end-use, 2023-2032, (USD Million)
TABLE 322. MEA lung cancer market, by country, 2018-2022, (USD Million)
TABLE 323. MEA lung cancer market, by country, 2023-2032, (USD Million)
TABLE 324. MEA lung cancer market, by diagnostics & therapy, 2018-2022, (USD Million)
TABLE 325. MEA lung cancer market, by diagnostics & therapy, 2023-2032, (USD Million)
TABLE 326. MEA lung cancer market, by diagnostics, 2018-2022, (USD Million)
TABLE 327. MEA lung cancer market, by diagnostics, 2023-2032, (USD Million)
TABLE 328. MEA lung cancer market, by therapy, 2018-2022, (USD Million)
TABLE 329. MEA lung cancer market, by therapy, 2023-2032, (USD Million)
TABLE 330. MEA lung cancer market, by non-invasive, 2018-2022, (USD Million)
TABLE 331. MEA lung cancer market, by non-invasive, 2023-2032, (USD Million)
TABLE 332. MEA lung cancer market, by minimally invasive, 2018-2022, (USD Million)
TABLE 333. MEA lung cancer market, by minimally invasive, 2023-2032, (USD Million)
TABLE 334. MEA lung cancer market, by indication, 2018-2022, (USD Million)
TABLE 335. MEA lung cancer market, by indication, 2023-2032, (USD Million)
TABLE 336. MEA lung cancer market, by end-use, 2018-2022, (USD Million)
TABLE 337. MEA lung cancer market, by end-use, 2023-2032, (USD Million)
TABLE 338. South Africa lung cancer market, by diagnostics & therapy, 2018-2022, (USD Million)
TABLE 339. South Africa lung cancer market, by diagnostics & therapy, 2023-2032, (USD Million)
TABLE 340. South Africa lung cancer market, by diagnostics, 2018-2022, (USD Million)
TABLE 341. South Africa lung cancer market, by diagnostics, 2023-2032, (USD Million)
TABLE 342. South Africa lung cancer market, by therapy, 2018-2022, (USD Million)
TABLE 343. South Africa lung cancer market, by therapy, 2023-2032, (USD Million)
TABLE 344. South Africa lung cancer market, by non-invasive, 2018-2022, (USD Million)
TABLE 345. South Africa lung cancer market, by non-invasive, 2023-2032, (USD Million)
TABLE 346. South Africa lung cancer market, by minimally invasive, 2018-2022, (USD Million)
TABLE 347. South Africa lung cancer market, by minimally invasive, 2023-2032, (USD Million)
TABLE 348. South Africa lung cancer market, by indication, 2018-2022, (USD Million)
TABLE 349. South Africa lung cancer market, by indication, 2023-2032, (USD Million)
TABLE 350. South Africa lung cancer market, by end-use, 2018-2022, (USD Million)
TABLE 351. South Africa lung cancer market, by end-use, 2023-2032, (USD Million)
TABLE 352. Saudi Arabia lung cancer market, by diagnostics & therapy, 2018-2022, (USD Million)
TABLE 353. Saudi Arabia lung cancer market, by diagnostics & therapy, 2023-2032, (USD Million)
TABLE 354. Saudi Arabia lung cancer market, by diagnostics, 2018-2022, (USD Million)
TABLE 355. Saudi Arabia lung cancer market, by diagnostics, 2023-2032, (USD Million)
TABLE 356. Saudi Arabia lung cancer market, by therapy, 2018-2022, (USD Million)
TABLE 357. Saudi Arabia lung cancer market, by therapy, 2023-2032, (USD Million)
TABLE 358. Saudi Arabia lung cancer market, by non-invasive, 2018-2022, (USD Million)
TABLE 359. Saudi Arabia lung cancer market, by non-invasive, 2023-2032, (USD Million)
TABLE 360. Saudi Arabia lung cancer market, by minimally invasive, 2018-2022, (USD Million)
TABLE 361. Saudi Arabia lung cancer market, by minimally invasive, 2023-2032, (USD Million)
TABLE 362. Saudi Arabia lung cancer market, by indication, 2018-2022, (USD Million)
TABLE 363. Saudi Arabia lung cancer market, by indication, 2023-2032, (USD Million)
TABLE 364. Saudi Arabia lung cancer market, by end-use, 2018-2022, (USD Million)
TABLE 365. Saudi Arabia lung cancer market, by end-use, 2023-2032, (USD Million)
TABLE 366. UAE lung cancer market, by diagnostics & therapy, 2018-2022, (USD Million)
TABLE 367. UAE lung cancer market, by diagnostics & therapy, 2023-2032, (USD Million)
TABLE 368. UAE lung cancer market, by diagnostics, 2018-2022, (USD Million)
TABLE 369. UAE lung cancer market, by diagnostics, 2023-2032, (USD Million)
TABLE 370. UAE lung cancer market, by therapy, 2018-2022, (USD Million)
TABLE 371. UAE lung cancer market, by therapy, 2023-2032, (USD Million)
TABLE 372. UAE lung cancer market, by non-invasive, 2018-2022, (USD Million)
TABLE 373. UAE lung cancer market, by non-invasive, 2023-2032, (USD Million)
TABLE 374. UAE lung cancer market, by minimally invasive, 2018-2022, (USD Million)
TABLE 375. UAE lung cancer market, by minimally invasive, 2023-2032, (USD Million)
TABLE 376. UAE lung cancer market, by indication, 2018-2022, (USD Million)
TABLE 377. UAE lung cancer market, by indication, 2023-2032, (USD Million)
TABLE 378. UAE lung cancer market, by end-use, 2018-2022, (USD Million)
TABLE 379. UAE lung cancer market, by end-use, 2023-2032, (USD Million)
Charts & Figures
FIG. 1 Top-down approach
FIG. 2 Breakdown of primary participants
FIG. 3 Lung cancer industry, 3600 synopsis, 2018 - 2032
FIG. 4 Industry segmentation
FIG. 5 Industry landscape 2018-2032 (USD Million)
FIG. 6 Growth potential analysis, by diagnostics & therapy
FIG. 7 Growth potential analysis, by indication
FIG. 8 Growth potential analysis, by end-use
FIG. 9 Company matrix analysis, 2022
FIG. 10 Company market share analysis, 2022
FIG. 11 Competitive dashboard